Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Difficulty demonstrating estradiol-mediated Erk1/2 phosphorylation in MCF-7 cells.

Stacey L Brower1, Jenny R Roberts, James M Antonini

  • 1Department of Biochemistry and Molecular Pharmacology, Mary Babb Randolph Cancer Center, West Virginia University Health Sciences Center, Morgantown, WV 26506-9142, USA.

The Journal of Steroid Biochemistry and Molecular Biology
|July 16, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Analysis Reveals Climate Exposure and Conservation Opportunities for a Vulnerable Life History in Steelhead (<i>Oncorhynchus mykiss</i>).

Evolutionary applications·2026
Same author

Short-Term Outcomes in Neonates Born to Diabetic Mothers During the Coronavirus Disease 2019 Pandemic: A Descriptive Study.

AJP reports·2026
Same author

Post-cardiac arrest care during transport from referral centers to a tertiary children's hospital.

Resuscitation plus·2026
Same author

Evaluating intramuscular epinephrine in pediatric out-of-hospital cardiac arrest (the PRIME trial): study protocol for a multi-centre, stepped-wedge cluster quasi-randomized controlled trial.

Trials·2026
Same author

The Vigilance Gradient: Nine Years of Adverse Event Trends in Pediatric Critical Care.

Critical care explorations·2026
Same author

Management of serious <i>Staphylococcus aureus</i> infections in children: A survey of paediatric infectious diseases physicians in Canada.

Paediatrics & child health·2026

Estradiol (E2) does not activate extracellular-signal regulated kinase (Erk1/2) in breast cancer cells. Conflicting reports may stem from experimental conditions, particularly serum presence, influencing Erk1/2 phosphorylation.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cancer Research

Background:

  • Conflicting reports exist regarding estradiol (E2) activation of extracellular-signal regulated kinase (Erk1/2) in MCF-7 breast cancer cells.
  • Understanding E2's effect on Erk1/2 is crucial due to its potential role in breast cancer progression.

Purpose of the Study:

  • To resolve discrepancies in the literature concerning E2-induced Erk1/2 activation in MCF-7 cells.
  • To identify experimental variables influencing Erk1/2 phosphorylation in response to E2.

Main Methods:

  • Utilized a high-throughput assay to quantify Erk1/2 phosphorylation.
  • Investigated variables including serum presence, cell sublines, culture density, E2 formulations, and solvents.
  • Normalized phosphorylated Erk1/2 levels to total cellular protein due to antibody cross-reactivity issues.

Related Experiment Videos

Main Results:

  • E2 with minimal stripped serum induced Erk1/2 phosphorylation, but this was primarily attributed to serum factors.
  • E2 in serum-free medium did not significantly alter Erk1/2 phosphorylation across tested conditions.
  • Phosphatase inhibitors increased general Erk1/2 phosphorylation but did not affect E2-mediated changes.

Conclusions:

  • Estradiol alone does not appear to significantly activate Erk1/2 in MCF-7 cells under standard experimental conditions.
  • The presence of serum factors in experimental media is a critical variable that can confound results regarding E2's effect on Erk1/2.
  • Further research is needed to fully elucidate the complex interactions influencing E2-mediated signaling pathways in breast cancer.